Neutra Corp. Discusses Operations and Objectives in Exclusive NetworkNewsWire Audio Interview
29 août 2019 08h30 HE
|
Neutra Corp.
NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- Neutra Corp. (OTCQB: NTRR) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a...
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28 août 2019 07h45 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
09 juil. 2019 08h00 HE
|
BioDelivery Sciences International, Inc.
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July 09, 2019 (GLOBE...
Tree of Knowledge and DR-HO’S Collaborate on Patient Education and Pain Relief
06 juin 2019 07h30 HE
|
Tree of Knowledge International Corp.
TORONTO, ON, June 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tree of Knowledge International Corp. (CSE: TOKI; OTCBB: TOKIF) (the “Company” or “TOK”) is pleased to announce it has joined VGH...
BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations
06 mai 2019 16h05 HE
|
BioDelivery Sciences International, Inc.
BELBUCA® Net Sales Increased by 134% versus Prior Year to All-time High of $18.7 MillionSymproic® Acquisition and Commercial Integration Successfully CompletedCompany Raises Full-Year BELBUCA Net...
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock
10 avr. 2019 16h07 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., April 10, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) (“BDSI” or the “Company”) today announced that it is commencing an underwritten public...
BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
21 févr. 2019 07h45 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®
04 févr. 2019 08h03 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences Appoints Terry Coelho as Chief Financial Officer
15 janv. 2019 07h30 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Jan. 15, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioElectronics Announces FDA Market Clearance Update
27 nov. 2018 09h31 HE
|
BioElectronics Corporation
FREDERICK, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced that the U.S. Food...